Yahoo
BSE - Delayed Quote INR

Decipher Labs Limited (DECIPHER.BO)

5.15 -0.34 (-6.19%)
At close: 3:15:01 PM GMT+5:30
Chart Range Bar
Loading chart for DECIPHER.BO
  • Previous Close 5.49
  • Open 5.79
  • Bid 5.10 x --
  • Ask 5.15 x --
  • Day's Range 5.15 - 5.79
  • 52 Week Range 4.81 - 10.99
  • Volume 1,192
  • Avg. Volume 4,075
  • Market Cap (intraday) 52.015M
  • Beta (5Y Monthly) 0.82
  • PE Ratio (TTM) --
  • EPS (TTM) -3.02
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Decipher Labs Limited, together with its subsidiaries, manufactures, markets, sells, and trades in pharmaceutical drugs in India and internationally. It operates through two segments, Manufacturing and Trading of Pharmaceutical Drugs and Consultancy. The company offers branded and finished formulations, bulk drugs, and chemicals. It also provides information technology (IT) consultancy services comprising technology integration and systems consulting, software development consulting, and management of IT projects. In addition, the company offers ERP implementation, mobile and cloud solutions, product development, and offshore services. It serves formulators, manufacturers, and research and development agencies. The company was formerly known as Combat Drugs Limited and changed its name to Decipher Labs Limited in January 2020. Decipher Labs Limited was incorporated in 1986 and is based in Hyderabad, India.

decipherlabs.in

1

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/29/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

DECIPHER.BO
50.72%
S&P BSE SENSEX (^BSESN)
12.99%

1-Year Return

DECIPHER.BO
47.02%
S&P BSE SENSEX (^BSESN)
12.76%

3-Year Return

DECIPHER.BO
67.69%
S&P BSE SENSEX (^BSESN)
16.26%

5-Year Return

DECIPHER.BO
82.83%
S&P BSE SENSEX (^BSESN)
25.03%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -13.31%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    138.51M

  • Net Income Avi to Common (ttm)

    -18.43M

  • Diluted EPS (ttm)

    -3.02

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    7.43M

  • Total Debt/Equity (mrq)

    2.43%

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: